ProCE Banner Activity

Management Options for NTRK Fusion–Positive Patients With Head and Neck Cancer: Slides

Slideset Download
Download these slides to review the use of NTRK inhibitors in patients with head and neck cancer.

Released: December 22, 2020

Expiration: December 21, 2021

No longer available for credit.

Share

Faculty

Aarti Bhatia

Aarti Bhatia, MD, MPH

Assistant Professor
Division of Medical Oncology
Department of Internal Medicine
Yale Cancer Center
New Haven, Connecticut

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Aarti Bhatia, MD, MPH

Assistant Professor
Division of Medical Oncology
Department of Internal Medicine
Yale Cancer Center
New Haven, Connecticut